Form 4: Amphastar Pharmaceuticals Executives Transfer Shares in Non-Derivative Transactions

Amphastar Pharmaceuticals' CEO and COO transferred 125,000 shares each of common stock as gifts, resulting in changes to their beneficial ownership.

Summary

• Jack Y. Zhang, CEO and Chief Scientific Officer of Amphastar Pharmaceuticals, transferred 125,000 shares of common stock as a gift.
• Following the transaction, Mr. Zhang directly owns 2,508,554 shares and indirectly owns 1,104,756 shares.
• Mary Z. Luo, COO, Chief Scientist, and Chairman, also transferred 125,000 shares of common stock as a gift.
• The shares held indirectly by Ms. Luo are held of record by Applied Physics and Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
• The transactions were executed on November 11, 2024, and reported on November 12, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transfers, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the ownership changes of key executives.

Comparison to Industry Standards

• The reporting of insider transactions via SEC Form 4 is a standard practice for all publicly traded companies in the United States.
• Similar filings are made by executives at companies like Teva Pharmaceuticals, Mylan, and Pfizer when they engage in transactions involving their company's stock.
• The level of detail provided in this filing is consistent with the requirements of the SEC and is comparable to other companies' filings.

Related Party Transactions

• The shares held indirectly by Ms. Luo are held of record by Applied Physics and Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.

Stakeholder Impact

• The stock transfers do not have a direct impact on stakeholders, as they are gifts and not market transactions.
• The filing provides transparency to shareholders regarding executive ownership.

Key Dates

Keywords

Amphastar Pharmaceuticals, stock transfer, beneficial ownership, SEC Form 4, executive transactions, insider trading, share gifting